President Trump’s nominee to head the Centers for Disease Control and Prevention secured backing from a pivotal Republican lawmaker after revisions were made to the agency’s website addressing concerns about vaccines and autism. Senator Bill Cassidy, a Louisiana Republican and Senate health committee chairman, announced his endorsement, citing changes to the site that now include a disclaimer emphasizing ongoing scientific inquiry into autism’s causes.
Dr. Erica Schwartz, previously a deputy surgeon general, faced intense scrutiny during her confirmation hearing over her willingness to counter Health Secretary Robert F. Kennedy Jr.’s vaccine skepticism. While the modified webpage still acknowledges the lack of evidence linking vaccines to autism, the addition of language stating scientists “have not identified the root causes” of autism was a key point of compromise. Senator Cassidy, a physician, framed his support as a step toward restoring public trust, though he acknowledged broader challenges in addressing vaccine misinformation.
Upon voting against Dr. Schwartz’s confirmation, Senate Majority Leader Chuck Schumer highlighted bipartisan concerns about H.H.S. leadership under Mr. Kennedy, who has pushed for the CDC website revision despite opposition from public health experts. “This is not about partisan politics—it’s about protecting our children’s health,” Schumer stated during the Senate floor session. Dr. Schwartz, who testified last week, reiterated her commitment to vaccine safety but did not directly address skepticism about her ability to resist White House pressures.
The nomination vote, initially slated for Thursday, was postponed until next week due to the absence of Senator Lisa Murkowski, who is attending to a family matter. Despite tensions with Mr. Kennedy over his vaccine stance, Senator Cassidy emphasized his confidence in Dr. Schwartz’s qualifications, stating, “She understands the importance of reassuring families and scientists alike.”
The revised CDC page on autism and vaccines, now free of direct references to Senator Cassidy’s objections, asserts that the agency “continues to support rigorous scientific research” and will update its materials as new evidence emerges. This follows last year’s directive from Mr. Kennedy to overhaul the site’s messaging, a move that alarmed health professionals but aligned with his own skepticism about vaccine safety.
The CDC nomination process has stalled for most of President Trump’s second term, with previous nominees Dr. David Weldon and Dr. Susan Monarez facing confirmation hurdles or political pushback. As of Thursday, the agency has operated under acting leadership for 335 of Trump’s 779 days in office. With Mr. Cassidy’s endorsement, Dr. Schwartz’s nomination is poised to advance, potentially along party lines, pending full Senate approval.
Also Read
- Global Shift to Healthier Diets Could Reduce Agricultural Emissions by 85%, Study Finds
- FDA Investigates Cyclospora Outbreak Amid Rising Food Safety Concerns; Bipartisan Insulin Legislation Advances; Medical School Racial Admissions Probe Expands
- Eli Lilly’s Retatrutide Demonstrates Significant Weight Loss While Leaving Cardiovascular Benefit Unclear
- FDA Advisory Committee Heads to Decision on Re-Authorizing Peptide Injections

